Rice R H, Rong X H, Chakravarty R
Charles A. Dana Laboratory of Toxicology, Harvard School of Public Health, Boston, MA 02115.
Biochem J. 1990 Jan 15;265(2):351-7. doi: 10.1042/bj2650351.
Human keratinocytes express a particulate transglutaminase that can be released from the membrane by limited proteolysis with trypsin or plasmin to yield a form that is congruent to 80 kDa. The enzyme from cultured cells was also releasable by endogenous proteolysis to yield a catalytically active fragment of congruent to 80 kDa. Endogenous release was strongly dependent upon temperature and Ca2+ concentration and was inhibited by iodoacetate, but not by leupeptin, antipain or phenylmethanesulphonyl fluoride. These phenomena raise the possibility of partial translocation of transglutaminase activity to the cytoplasm by proteolysis to which the enzyme is subject during terminal differentiation. In addition, hydrodynamic measurements showed that the endogenously released enzyme was monomeric in solution (79 kDa), whereas that solubilized by hydroxylamine without proteolysis appeared dimeric (190 kDa). The latter dimeric state may reflect either an altered conformation of the enzyme or post-translational modification beyond fatty acid esterification.
人角质形成细胞表达一种颗粒性转谷氨酰胺酶,该酶可通过用胰蛋白酶或纤溶酶进行有限的蛋白水解作用从细胞膜上释放出来,产生一种与80 kDa一致的形式。来自培养细胞的该酶也可通过内源性蛋白水解作用释放出来,产生一个与80 kDa一致的具有催化活性的片段。内源性释放强烈依赖于温度和Ca2+浓度,并受到碘乙酸盐的抑制,但不受亮抑酶肽、抗蛋白酶或苯甲基磺酰氟的抑制。这些现象增加了转谷氨酰胺酶活性在终末分化过程中通过该酶所经历的蛋白水解作用部分转移至细胞质的可能性。此外,流体动力学测量表明,内源性释放的酶在溶液中是单体形式(79 kDa),而未经蛋白水解作用由羟胺溶解的酶则呈现二聚体形式(190 kDa)。后一种二聚体状态可能反映了该酶构象的改变或脂肪酸酯化之外的翻译后修饰。